IPO

With its direct listing, QumulusAI isn't just going public; it's signaling a strategic maneuver to solve the AI compute crisis outside the hyperscaler shadow.

Cypriot banktech Xryma Plc is listing on Euronext Paris without raising a cent. We explore the strategy behind this unconventional move and its deep infrastructure play.

Following SK Hynix's record-breaking Nasdaq listing, new leveraged ETFs offer a way to bet big on the AI chip giant. But are these tools for traders or traps for the unwary?

A C$11.5 million deal for a company you've never heard of is set to accelerate the takeover of independent pharmacies. Is it a lifeline or the end of an era?

A small biotech is raising millions with a high-risk funding plan to launch a BOTOX alternative. Can it survive long enough to disrupt a pharma titan?

Erasca secures $550M to advance its attack on the notorious RAS/MAPK pathway. A look at the science, the strategy, and what it means for oncology.

Rithm Property Trust is raising cash to buy multifamily loans from its own manager. Is this a savvy move in a tough market or a risky inside deal?

Amid a disciplined SPAC market resurgence, Samos Energy's new fund targets cash-generating assets, signaling a strategic pivot back to energy security.

NUBURU is launching a bold, premium-priced $38M offering to acquire Tekne, clear its books, and secure its NYSE listing in a high-stakes pivot to defense.

Fresh from a 2020 bankruptcy, the menswear giant behind Men's Wearhouse is going public. Can it convince Wall Street that suits and stores have a future?

The Chinese battery firm secures vital funds, but a plunging stock price and fierce competition reveal the high stakes of its survival strategy.

With a historic $26.5B NASDAQ listing, SK hynix solidifies its crucial role in the AI supply chain, escalating the high-stakes race for memory dominance.

The biotech's complex warrant restructuring is more than a balance sheet clean-up; it's a strategic masterstroke paving the way for its MASH drug.

Sivers Semiconductors pushed its earnings dates. This isn't a sign of trouble; it's the steep cost of admission to Wall Street's premier league.

Led by a serial SPAC sponsor, Mercator Acquisition Corp. tests a cautious market, targeting tech disruptors in finance and real estate. Is this the new model?

Freedom Metals Acquisition Corp. launches a $275M IPO, betting on the high-stakes critical minerals sector in a newly disciplined SPAC market.

After a surge on strong delivery news, Rivian's plan to sell 75 million new shares tests investor faith, revealing the immense cost of its EV ambitions.

Intiva Health's $TIVA token is hitting a global exchange just as its AI platform tackles a huge administrative bottleneck. Is this the future of professional trust?

As IQM Quantum Computers prepares for its Nasdaq Helsinki debut, the move signals a new phase for deep tech and Europe's role in the global quantum race.